693 related articles for article (PubMed ID: 29090592)
1. Genome editing technologies to fight infectious diseases.
Trevisan M; Palù G; Barzon L
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):1001-1013. PubMed ID: 29090592
[TBL] [Abstract][Full Text] [Related]
2. Non-viral delivery of genome-editing nucleases for gene therapy.
Wang M; Glass ZA; Xu Q
Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
[TBL] [Abstract][Full Text] [Related]
3. Engineered Viruses as Genome Editing Devices.
Chen X; Gonçalves MA
Mol Ther; 2016 Mar; 24(3):447-57. PubMed ID: 26336974
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.
Okoli A; Okeke MI; Tryland M; Moens U
Viruses; 2018 Jan; 10(1):. PubMed ID: 29361752
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
6. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
7. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
8. Genome editing: the road of CRISPR/Cas9 from bench to clinic.
Eid A; Mahfouz MM
Exp Mol Med; 2016 Oct; 48(10):e265. PubMed ID: 27741224
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
10. Designed nucleases for targeted genome editing.
Lee J; Chung JH; Kim HM; Kim DW; Kim H
Plant Biotechnol J; 2016 Feb; 14(2):448-62. PubMed ID: 26369767
[TBL] [Abstract][Full Text] [Related]
11. Genome Editing in Stem Cells for Disease Therapeutics.
Song M; Ramakrishna S
Mol Biotechnol; 2018 Apr; 60(4):329-338. PubMed ID: 29516417
[TBL] [Abstract][Full Text] [Related]
12. The genome editing revolution: A CRISPR-Cas TALE off-target story.
Stella S; Montoya G
Bioessays; 2016 Jul; 38 Suppl 1():S4-S13. PubMed ID: 27417121
[TBL] [Abstract][Full Text] [Related]
13. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of viral vectors as vehicles for DMD gene editing.
Maggio I; Chen X; Gonçalves MA
Genome Med; 2016 May; 8(1):59. PubMed ID: 27215286
[TBL] [Abstract][Full Text] [Related]
15. Concerns regarding 'off-target' activity of genome editing endonucleases.
Kadam US; Shelake RM; Chavhan RL; Suprasanna P
Plant Physiol Biochem; 2018 Oct; 131():22-30. PubMed ID: 29653762
[TBL] [Abstract][Full Text] [Related]
16. Generating a Genome Editing Nuclease for Targeted Mutagenesis in Human Cells.
He Z; Kee K
Methods Mol Biol; 2017; 1498():153-162. PubMed ID: 27709574
[TBL] [Abstract][Full Text] [Related]
17. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
18. The Anti-CRISPR Story: A Battle for Survival.
Maxwell KL
Mol Cell; 2017 Oct; 68(1):8-14. PubMed ID: 28985512
[TBL] [Abstract][Full Text] [Related]
19. Genome editing comes of age.
Kim JS
Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
[TBL] [Abstract][Full Text] [Related]
20. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
